• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHB2200138 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2022-09-18 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2400184 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300221 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHB2400164 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2024-09-30 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2400020 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-01-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300234 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400015 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-01-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300220 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400192 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2101061 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-05-27 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHB2400106 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2024-06-14 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2300218 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400195 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300243 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-22 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400185 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300210 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHB2400165 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2024-09-30 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2400018 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-01-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHB2200139 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2022-09-18 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2300231 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-18 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view